Memo

New poll shows strong support for President Biden’s agenda lowering prescription drug prices and standing up to big drug companies

Economic Security and Corporate Power
May 2, 2024

This week, Navigator Research released new polling on the issue. This memo details the strong support demonstrated by this poll for Medicare drug price negotiation, disapproval of Big Pharma and their congressional allies, and the public’s rejection of Big Pharma’s misinformation and spin.

Press Releases

Watchdog: Bristol Myers, J&J’s Greed Put in Check As Judge Rejects Latest Challenge to Biden Rx Medicare Negotiation Action

Economic Security and Corporate Power
April 30, 2024

In a major win for seniors and patients struggling to afford their necessary medications, on Monday a U.S. District Judge rejected lawsuits from Bristol Myers Squibb and Johnson & Johnson seeking to block the Inflation Reduction Act’s measures giving Medicare the power to negotiate lower prices directly with drug manufacturers.

back to top